i2o

is a Massachusetts-based biotechnology company that researches and develops oral peptide and protein therapies for the treatment of cardiometabolic diseases...
Read more
i2o Chairman & CEO: Kurt Graves

Chairman & CEO

Kurt Graves

CEO Approval Rating

90/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$86.4M

Trending Companies